Advertisements
Advertisements
प्रश्न
Consult the internet and find out how to make orally active protein pharmaceuticals. What is the major problem to be encountered?
Advertisements
उत्तर १
Orally active protein pharmaceuticals contain biologically active materials such as peptides or proteins, antibodies, and polymeric beads. The body administers it orally through various formulations. It involves encapsulating protein or peptide in liposomes or formulations using penetration enhancers. People use these proteins or peptides as vaccines and for the treatment of various diseases. However, the oral administration of these peptides or proteins presents several related challenges. Once ingested, the stomach juices’ proteases denature these proteins. This will nullify their effect. Therefore, it is essential to protect the therapeutic protein from digestive enzymes when it is taken orally. We inject the proteins directly into the target site to meet this requirement.
उत्तर २
Proteinaceous drugs cannot be taken orally because they can be degraded by the proteases of our alimentary canal. To counteract this problem or to make an orally active protein pharmaceutical, it must be coated with a film that is resistant to protein-degrading enzymes.
APPEARS IN
संबंधित प्रश्न
Explain enzyme – replacement therapy to treat adenosine deaminase deficiency. Mention two disadvantages of this procedure.
Write the function of adenosine deaminase enzyme.
Suggest any two possible treatments that can be given to a patient exhibiting adenosine deaminase deficiency.
What is gene therapy? Illustrate using the example of adenosine deaminase (ADA) deficiency.
Can you suggest a method to remove oil (hydrocarbon) from seeds based on your understanding of rDNA technology and the chemistry of oil?
Expand the Given and mention one application of each:
ELISA
Explain how insulin can be produced using recombinant DNA technology.
Give a schematic representation of the transformation of a pro-insulin into insulin.
Answer the following question.
Explain the various steps involved in the production of artificial insulin.
The genetic defect adenosine deaminase deficiency may be cured permanently by ____________.
PCR proceeds in three distinct steps governed by temperature, they are in order of ____________.
ELISA is mainly used for ____________.
Vaccines that use components of a pathogenic organism rather than the whole organism are called ____________.
Mention the number of primers required in each cycle of PCR. Write the role of primers and DNA polymerase in PCR. Name the source organism of the DNA polymerase used in PCR.
ELISA technique is based on the principles of antigen-antibody interaction. Can this technique be used in the molecular diagnosis of a genetic disorder, such as phenylketonuria?
A patient suffering from diabetes mellitus will have ______.
Due to which of the following reasons insulin extracted from pancreas of slaughtered animals cannot be used in humans to treat diabetes?
When gene targetting involving gene amplification is attempted in an individual’s tissue to treat disease, it is known as ______
Which of the following is not an application of PCR (Polymerase Chain Reaction)?
For effective treatment of the disease, early diagnosis and understanding of its pathophysiology is very important. Which of the following molecular diagnostic techniques is very useful for early detection?
Discuss briefly how a probe is used in molecular diagnostics.
Taking examples under each category, discuss upstream and downstream processing.
How is a mature, functional insulin hormone different from its prohormone form?
List the advantages of recombinant insulin.
Name the five key tools for accomplishing the tasks of recombinant DNA technology. Also mention the functions of each tool.
The ______ gene from Bacillus thuringiensis produces a protein that forms crystalline inclusions in bacterial spores.
